Weiqiang Chen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Venues

Science advances

PloS one

Science translational medicine

Feinstein Institute for Medical Research

Tianjin Institute of Health and Environmental Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Feinstein Institute for Medical Research

United States

Research scholar

Shunho Cell Biotech (Tianjin) Co., Ltd.

China

Senior researcher :: Research & Develop

Tianjin Institute of Health and Environmental Medicine

China

Associate professor

Tianjin Institute of Health and Environmental Medicine

China

Assistant professor

Education History

Tianjin Institute of Health and Environmental Medicine

China

PHD

Shandong Medical University

China

BSC

Publications

Cassie Shu Zhu, Xiaoling Qiang, Weiqiang Chen, Jianhua Li, Xiqian Lan, Huan Yang, Jonathan Gong, Lance B Becker, Ping Wang, Kevin J Tracey, Haichao Wang
Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis. Science advances 9 (5) (2023)
Cassie Shu Zhu, Xiaoling Qiang, Weiqiang Chen, Jianhua Li, Xiqian Lan, Huan Yang, Jonathan Gong, Lance B Becker, Ping Wang, Kevin J Tracey, Haichao Wang
Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis. Science advances 9 (5) (2023)
Cassie Shu Zhu, Xiaoling Qiang, Weiqiang Chen, Jianhua Li, Xiqian Lan, Huan Yang, Jonathan Gong, Lance B Becker, Ping Wang, Kevin J Tracey, Haichao Wang
Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis. Science advances 9 (5) (2023)
Cassie Shu Zhu, Xiaoling Qiang, Weiqiang Chen, Jianhua Li, Xiqian Lan, Huan Yang, Jonathan Gong, Lance B Becker, Ping Wang, Kevin J Tracey, Haichao Wang
Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis. Science advances 9 (5) (2023)
Cassie Shu Zhu, Xiaoling Qiang, Weiqiang Chen, Jianhua Li, Xiqian Lan, Huan Yang, Jonathan Gong, Lance B Becker, Ping Wang, Kevin J Tracey, Haichao Wang
Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis. Science advances 9 (5) (2023)
Cassie Shu Zhu, Xiaoling Qiang, Weiqiang Chen, Jianhua Li, Xiqian Lan, Huan Yang, Jonathan Gong, Lance B Becker, Ping Wang, Kevin J Tracey, Haichao Wang
Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis. Science advances 9 (5) (2023)
Cassie Shu Zhu, Xiaoling Qiang, Weiqiang Chen, Jianhua Li, Xiqian Lan, Huan Yang, Jonathan Gong, Lance B Becker, Ping Wang, Kevin J Tracey, Haichao Wang
Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis. Science advances 9 (5) (2023)
Weiqiang Chen, Xiaoling Qiang, Yongjun Wang, Cassie Shu Zhu, Jianhua Li, Ariella Babaev, Huan Yang, Jonathan Gong, Lance B Becker, Ping Wang, Kevin J Tracey, Haichao Wang
Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis. Science translational medicine 12 (539) (2021)
Xiaoling Zhao, Renjia Li, Hui Jin, Haimin Jin, Yonghui Wang, Wanqi Zhang, Haichao Wang, Weiqiang Chen
Epigallocatechin-3-gallate confers protection against corticosterone-induced neuron injuries via restoring extracellular signal-regulated kinase 1/2 and phosphatidylinositol-3 kinase/protein kinase B signaling pathways. PloS one 13 (1) (2018)

Weiqiang Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Weiqiang Chen